https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-22 / Cytotherapy 2018 Nov;20(11):1309-1323
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-22 / Cytotherapy 2018 Nov;20(11):1309-13232018-10-22 00:00:002019-04-03 09:49:17Empowering dendritic cell cancer vaccination: the role of combinatorial strategies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-17 / 2018 Oct;10(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-17 / 2018 Oct;10(10)2018-10-17 00:00:002018-10-17 00:00:00Immune Function and Micronutrient Requirements Change over the Life Course
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-12 / Hum Vaccin Immunother 2019;15(2):397-406
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-12 / Hum Vaccin Immunother 2019;15(2):397-4062018-10-12 00:00:002019-03-25 10:39:48Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-11 / Exp Ther Med 2018 Dec;16(6):5123-5129
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-11 / Exp Ther Med 2018 Dec;16(6):5123-51292018-10-11 00:00:002018-10-11 00:00:00Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-10 / Cancer Immunol. Immunother. 2019 Jan;68(1):121-130
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-10 / Cancer Immunol. Immunother. 2019 Jan;68(1):121-1302018-10-10 00:00:002019-03-25 10:37:19Phase I/II clinical trial of a Wilms‘ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-08 / 2018 10;46(5):1147-1159
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-08 / 2018 10;46(5):1147-11592018-10-08 00:00:002018-10-08 00:00:00Vitamin C and immune cell function in inflammation and cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-01 / Front Immunol 2018;9:2265
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-01 / Front Immunol 2018;9:22652018-10-01 00:00:002019-02-15 08:36:04Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-10-01 / Am J Clin Dermatol 2018 Oct;19(5):657-670
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-10-01 / Am J Clin Dermatol 2018 Oct;19(5):657-6702018-10-01 00:00:002018-10-01 00:00:00Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-29 / J Immunother Cancer 2018 Sep;6(1):96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-29 / J Immunother Cancer 2018 Sep;6(1):962018-09-29 00:00:002019-02-15 08:39:11A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-26 / Cancers (Basel) 2018 Sep;10(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-26 / Cancers (Basel) 2018 Sep;10(10)2018-09-26 00:00:002018-09-26 00:00:00The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
